News-Papers
Testimonial
Video Gallery
 | |||||
 |  |  |  |  |  |
Search
Follow us...
Latest
- Melatonin as a Potential Multitherapeutic Agent
- Ionizing Radiation as a Source of Oxidative Stress-The Protective Role of Melatonin and Vitamin D
- Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
- Melatonin and its ubiquitous anticancer effects
- Vitamin E deficiency impairs the somatostatinergic receptor-effector system and leads to phosphotyrosine phosphatase overactivation and cell death in the rat hippocampus
- Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
- Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
- High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer
- The impact of vitamin D on cancer: A mini review
- Solution of retinoids in vitamin E in the Di Bella Method biological multitherapy
- Somatostatin and Somatostatin Receptors in Tumour Biology
- Immunohistochemical expression of somatostatin receptor subtypes in prostate tissue from cystoprostatectomies with incidental prostate cancer
- Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
- Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells
- An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress
- Vitamin D Status in Pediatric Oncology Patients in Lebanon: A Comparison With Non-oncology Controls in a Case-Control Study
- Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
- Melatonin and cancer: From the promotion of genomic stability to use in cancer treatment
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Vademecum
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer